Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib-Reference-Cited by-同舟云学术

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Published:2016-08-24 Issue:41 Volume:7 Page:67142-67149
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gardini Andrea Casadei¹,Scarpi Emanuela²,Faloppi Luca³⁴,Scartozzi Mario⁴,Silvestris Nicola⁵,Santini Daniele⁶,de Stefano Giorgio⁷,Marisi Giorgia⁸,Negri Francesca V.⁹,Foschi Francesco Giuseppe¹⁰,Valgiusti Martina¹,Ercolani Giorgio¹¹¹²,Frassineti Giovanni Luca¹

Affiliation:

1. Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, Meldola, Italy

2. Unit of Biostatistics and Clinical Trials, IRST IRCCS, Meldola, Italy

3. Department of Medical Oncology, Ospedale Generale Provinciale di Macerata ASUR Marche AV3, Macerata, Italy

4. Department of Medical Oncology, University Hospital Cagliari, Cagliari, Italy

5. Medical Oncology Unit, Cancer Institute “Giovanni Paolo II”, Bari, Italy

6. Medical Oncology Department, University Campus Bio-Medico, Via Álvaro del Portillo, Rome, Italy

7. Infectious Diseases and Interventional Ultrasound Unit, D. Cotugno Hospital, Naples, Italy

8. Biosciences Laboratory, IRST IRCCS, Meldola, Italy

9. Medical Oncology Unit, University Hospital, Parma, Italy

10. DPT Internal Medicine, Faenza Hospital, Faenza, AUSL Romagna, Forli, Italy

11. Department of General Surgery, Morgagni-Pierantoni Hospiatal, AUSL Romagna, Forli, Italy

12. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients;Clinical Biochemistry;2024-10

2. Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib;Gastroenterology Research;2024-02

3. Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma;Seminars in Liver Disease;2023-11

4. Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma;Translational Gastroenterology and Hepatology;2023-10

5. Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment;Journal of Hepatocellular Carcinoma;2023-02